PhRMA, U.S. Chamber warn of unintended consequences, market effects of negotiations.
Pharma Industry
Latest News
Advertisement
CME Content
Advertisement
Administration, HHS tout milestone day on road to lowering drug prices for beneficiaries.
It's time for pharmaceutical companies and others to innovate and disrupt the distribution side of treatment.
Prescription drug prices, vaccine costs are also key issues.
In 2024, beneficiaries could see savings per dose, according to new guidance on price increases relative to inflation.
Public-private partnerships will crumble, hurting drug innovation and eventually patients, Republicans say.
Advertisement
Advertisement
Trending on Medical Economics
1
Health care lessons from Texas: How ACA insurance affects physicians and patients
2
DOJ sues Louisiana hospital operator over unnecessary care, referral practices; heart disease, stroke drive more than one-quarter of U.S. deaths; red light therapy vs. CTE – Morning Medical Update
3
Consolidation trends in the medical device industry in 2026
4
PBM profits obscured by accounting and mergers, USC report finds
5